SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PROTEOMICS
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: nigel bates who wrote (511)1/23/2004 5:17:40 PM
From: Gulo  Read Replies (1) of 539
 
How do you go about evaluating a company like SynX Pharma?
It uses proteomics to find biomarkers that identify a particular disease or condition, and then develops diagnostics based on those markers.

Some of its tests have competition, but it does have rapidly growing revenues and might go cash-flow positive within months. I hope so, anyway, because it will run out of money otherwise. I think there is a great deal of value hidden behind the financial uncertainty. The product line looks fairly interesting - no cancer cures, but a series of high-demand diagnostics with huge margins. It has a decent, albeit short, track record of executing on its plans.
fin-info.com

Any opinions? Have I found a gem, or am I dreaming?
-g
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News